Litcius/Paper detail

Circulating levels of calprotectin, a signature of neutrophil activation in prediction of severe respiratory failure in COVID-19 patients: a multicenter, prospective study (CalCov study)

Luis García de Guadiana‐Romualdo, Carlos Rodríguez Rojas, Daniel Morell‐García, David Andaluz‐Ojeda, María Dolores Rodríguez Mulero, Enrique Rodríguez–Borja, A Ballesteros-Vizoso, María Dolores Calvo, Lourdes Albert-Botella, Adela Pozo Giráldez, Isabel Llompart-Alabern, Cristina Bolado Jiménez, Marta Hernández Olivo, Lucía Fernández Presa, Juan Ortega-Pérez, María José Fora Romero, Valerio Campos‐Rodríguez, Andrea Ballester Férriz, Alexandra M. Guiu-Martí, Leyre Pinilla Arribas, María Galindo Martínez, Edwin R. Puerto-Lara, Ana Belen López Tarazaga, María Salomé Ros Braquehais, Leonor Nogales Martín, Celia Juez Santamaría, Wysalli Trapiello Fernández, Virginia Espinilla Fernández, Aleksandra Mandic Havelka, María Dolores Albaladejo-Otón

2021Inflammation Research31 citationsDOIOpen Access PDF

Topics & Concepts

CalprotectinMedicineInternal medicineMechanical ventilationIntensive care unitProspective cohort studyArea under the curvePopulationSeverity of illnessGastroenterologyEnvironmental healthDiseaseInflammatory bowel diseaseS100 Proteins and AnnexinsIntensive Care Unit Cognitive DisordersSepsis Diagnosis and Treatment
Circulating levels of calprotectin, a signature of neutrophil activation in prediction of severe respiratory failure in COVID-19 patients: a multicenter, prospective study (CalCov study) | Litcius